← Leaderboards
Christiane D. Wrann
Massachusetts General Hospital
$4,191,926
Attributed
$4,815,523
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,815,523 · 6
By mechanism
R01$2,010,215 · 1
R56$1,375,525 · 2
R00$744,871 · 1
R21$462,000 · 1
K99$222,912 · 1
Top collaborators
- Se Hoon Choi3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Zhongcong Xie$19,705,169
- Daniel Lingwood$10,946,577
- Se Hoon Choi$2,575,136
- Chongzhao Ran$9,592,256
- Can Martin Zhang$10,046,963
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCognitive FunctionMouse ModelClinical ResearchS DiseaseInnovationMolecularLearningMemoryNeurodegenerative DisordersAnimal ModelExerciseImpaired CognitionImpairmentBehavior TestFibronectinsMediatingNeurologicPublic Health RelevanceTransgenic MiceExperimental StudyNeuronsIn VivoGenetic
Grant awards (16)
FNDC5/irisin as a Molecular Mediator of Exercise Benefits in Cognitive Function$490,209
R01 · FY2025 · NS · contact PI
FNDC5/irisin as a Molecular Mediator of Exercise Benefits in Cognitive Function$477,112
R01 · FY2024 · NS · contact PI
FNDC5/irisin as a molecular mediator of exercise benefits in cognitive function$473,850
R01 · FY2023 · NS · contact PI
FNDC5/irisin as a molecular mediator of exercise benefits in cognitive function$37,350
R01 · FY2023 · NS · contact PI
FNDC5/irisin as a Molecular Mediator of Exercise Benefits in Cognitive Function$14,535
R01 · FY2023 · NS · contact PI
Exploring irisin as a novel target for Alzheimers Disease$785,194
R56 · FY2022 · AG · contact PI
FNDC5/irisin as a molecular mediator of exercise benefits in cognitive function$473,560
R01 · FY2022 · NS · contact PI
FNDC5/irisin as a molecular mediator of exercise benefits in cognitive function$43,599
R01 · FY2022 · NS · contact PI
Exploring irisin as a novel target for Alzheimer's Disease$210,000
R21 · FY2020 · AG · contact PI
Dissecting the molecular mediators of the neuroprotective effects of exercise in Alzheimer's Disease$590,331
R56 · FY2019 · AG · contact PI
Exploring irisin as a novel target for Alzheimer's Disease$252,000
R21 · FY2019 · AG · contact PI
Molecular mechanisms of exercise benefits in synapse plasticity and cognition$247,580
R00 · FY2019 · NS · contact PI
Molecular mechanisms of exercise benefits in synapse plasticity and cognition$248,291
R00 · FY2018 · NS · contact PI
Molecular mechanisms of exercise benefits in synapse plasticity and cognition$249,000
R00 · FY2017 · NS · contact PI
Molecular mechanisms of exercise benefits in synapse plasticity and cognition$111,456
K99 · FY2015 · NS · contact PI
Molecular mechanisms of exercise benefits in synapse plasticity and cognition$111,456
K99 · FY2014 · NS · contact PI